Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Rijken

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 26, 1998
The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulinE A Braat, P Los, D C Rijken
European Journal of Biochemistry|October 31, 2001
Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activatorE A Schenk-Braat, J Morser, D C Rijken
The Journal of Biological Chemistry|July 25, 1991
Binding of tissue-type plasminogen activator by the mannose receptorM Otter, M M Barrett-Bergshoeff, D C Rijken
Thrombosis and Haemostasis|December 17, 1985
On the composition and function of the carbohydrate moiety of tissue-type plasminogen activator from human melanoma cellsD C Rijken, J J Emeis, G J Gerwig
European Journal of Biochemistry|March 10, 1998
Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptorF Noorman, M M Barrett-Bergshoeff, D C Rijken
Thrombosis and Haemostasis|December 1, 1994
In vitro stability of a tissue-type plasminogen activator mutant, BM 06.022, in human plasmaD C Rijken, E Groeneveld, M M Barrett-Bergshoeff
The Journal of Biological Chemistry|May 30, 1997
On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase BD V Sakharov, E F Plow, D C Rijken
Acta Medica Scandinavica|January 1, 1987
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarctionJ Gram, J Jespersen, C Kluft, et al.
Thrombosis and Haemostasis|September 1, 1993
Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activatorG A de Munk, E Groeneveld, D C Rijken
The Journal of Clinical Investigation|November 1, 1991
Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulinG A de Munk, E Groeneveld, D C Rijken
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 26, 1998
The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulinE A Braat, P Los, D C Rijken
European Journal of Biochemistry|October 31, 2001
Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activatorE A Schenk-Braat, J Morser, D C Rijken
The Journal of Biological Chemistry|July 25, 1991
Binding of tissue-type plasminogen activator by the mannose receptorM Otter, M M Barrett-Bergshoeff, D C Rijken
Thrombosis and Haemostasis|December 17, 1985
On the composition and function of the carbohydrate moiety of tissue-type plasminogen activator from human melanoma cellsD C Rijken, J J Emeis, G J Gerwig
European Journal of Biochemistry|March 10, 1998
Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptorF Noorman, M M Barrett-Bergshoeff, D C Rijken
Thrombosis and Haemostasis|December 1, 1994
In vitro stability of a tissue-type plasminogen activator mutant, BM 06.022, in human plasmaD C Rijken, E Groeneveld, M M Barrett-Bergshoeff
The Journal of Biological Chemistry|May 30, 1997
On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase BD V Sakharov, E F Plow, D C Rijken
Acta Medica Scandinavica|January 1, 1987
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarctionJ Gram, J Jespersen, C Kluft, et al.
Thrombosis and Haemostasis|September 1, 1993
Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activatorG A de Munk, E Groeneveld, D C Rijken
The Journal of Clinical Investigation|November 1, 1991
Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulinG A de Munk, E Groeneveld, D C Rijken
Pageof 11